Article
A novel A20 (TNFAIP3) antibody (Ber-A20) can be used to detect unmutated A20 by immunohistology.
Histopathology - 1 May 2012
Hirsch Burkhard, Grünbaum Maria, Wagner Florian, Bi Yingwen, Lucka Lothar, Du Ming-Qing, Stein Harald, Dürkop Horst
Abstract excerpt
AIMS: A20 (TNFAIP3) is a nuclear factor-κB (NF-κB)-inducible component of tumour necrosis factor and Toll-like receptor intracellular signal transduction. It negatively regulates NF-κB, and has been identified as a tumour suppressor. Several studies have described A20 inactivation by deletion of the A20 locus at 6q23, inactivating mutations, and/or methylation of the A20 promoter in various lymphoma entities....
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
